378.2 𩺠åèç
378.2.1 é«é »èé»
378.2.1.1 ICH Etiology by Location
- Deep (basal ganglia, thalamus, pons, cerebellum): HTN
- Lobar (frontal, parietal, occipital, temporal): CAA in elderly, AVM/tumor in younger
378.2.1.4 STICH Trials
- STICH-I (2005), STICH-II (2013)
- No benefit for routine evacuation of supratentorial ICH
- Select cases may benefit
378.2.1.5 ENRICH (2024)
- Minimally invasive evacuation for lobar ICH
- Improved outcomes
- Changes practice for select lobar
378.2.1.6 Anticoagulation Reversal
| Drug | Reversal |
|---|---|
| Warfarin | 4-factor PCC + vitamin K |
| Dabigatran | Idarucizumab |
| Apixaban, rivaroxaban | Andexanet alfa (ANNEXA-I 2023 controversial) |
| Edoxaban | Andexanet (less data) |
| Heparin | Protamine |
378.2.1.8 SAH Presentation
- âWorst headache of lifeâ
- Thunderclap
- LOC ~ 50%
- Photophobia, meningismus (delayed)
- Sentinel headache (warning bleed)
378.2.1.9 SAH Workup
- CT (sensitive first 6 hr, ~ 100%)
- LP if CT negative (xanthochromia)
- CTA/DSA for aneurysm
378.2.1.10 Hunt-Hess Grades
- I: minimal
- II: moderate headache, no deficit
- III: confusion, mild deficit
- IV: stupor, moderate-severe
- V: coma
378.2.1.11 Aneurysm Treatment
- Coiling preferred (ISAT)
- Clipping for select (MCA, complex, young)
- Within 24-72 hr
378.2.1.13 Vasospasm
- Peak day 4-14
- TCD monitoring
- Euvolemia + induced HTN (NOT triple-H anymore)
- Endovascular for refractory
378.2.1.14 Hyponatremia in SAH
- Cerebral salt wasting (CSW) > SIADH
- Treat with salt + fluid (not restriction)
378.2.2 Specific Conditions
378.2.2.1 Cerebral Amyloid Angiopathy (CAA)
- Elderly
- Lobar ICH
- Often recurrent
- Microbleeds on T2*/SWI
- Boston criteria
- AVOID anticoagulation if possible